Pioneering ion channel team, 1990
ABOUT US

Our History 

Saniona Icon blue

Saniona was built on a foundation of more than 20 years of pioneering ion channel research

1

1989–2011

Leading ion channel scientific team established

Celebration in Glostrup with founding team members

2011

Saniona founded based on advanced ion channel discovery engine and compound library

Construction of Saniona’s research labs

2013

Saniona’s first spin-out, Ataxion.

Saniona advances preclinical GABA and K+ ion channel programs

2014

Saniona IPO in Stockholm.

Saniona’s compound library exceeds 1,000 compounds

Saniona compound library

2016

Saniona licenses tesofensine rights in Mexico and Argentina to Medix

2017

SAN711 selected for preclinical development.

Saniona spins out Scandion Oncology

2018

Positive Phase 2 data with Tesomet in Prader-Willi syndrome.

Proprietary compound library exceeds 20,000 compounds

2019

SAN903 selected for preclinical development

U.S. corporate office opened in 2020. (Credit: Chuck Choi)

2020

Positive Phase 2 data with Tesomet in hypothalamic obesity

U.S. corporate office and team established

2021

Orphan Drug Designation in HO and PWS

Created capsule formulation for Tesomet

Initiated Phase 1 trial of SAN711

Initiated Phase 2b trial of Tesomet for hypothalamic obesity